{"filing":{"accession_number":"0001213900-26-081438","cik":"0001560293","ticker":"TNONW","company_name":"Tenon Medical, Inc.","form":"8-K","filing_date":"2026-07-24","report_date":"2026-07-23","primary_document":"ea0299237-8k_tenon.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1560293/000121390026081438/ea0299237-8k_tenon.htm"},"events":[{"id":20499,"run_id":18451,"accession_number":"0001213900-26-081438","anchor_item_number":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This 8-K Item 5.07 discloses the results of Tenon Medical's 2026 Annual Meeting of Stockholders held on July 23, 2026. The filing reports voting outcomes on six matters: election of seven directors, ratification of auditors (Haskell \u0026 Whitee LLP), approval of a reverse stock split (1:2 to 1:35 ratio), approval of shares underlying convertible debt from March 2026 financing, approval of future dilutive issuances under Nasdaq rules, and adjournment authority. All six proposals were approved. The reverse stock split and dilutive issuance approvals are material capital structure events affecting shareholders.","company_name":"Tenon Medical, Inc.","ticker":"TNONW","filing_date":"2026-07-24","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":19872,"accession_number":"0001213900-26-081438","item_number":null,"item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This 8-K Item 5.07 discloses the results of Tenon Medical's 2026 Annual Meeting of Stockholders held on July 23, 2026. The filing reports voting outcomes on six matters: election of seven directors, ratification of auditors (Haskell \u0026 Whitee LLP), approval of a reverse stock split (1:2 to 1:35 ratio), approval of shares underlying convertible debt from March 2026 financing, approval of future dilutive issuances under Nasdaq rules, and adjournment authority. All six proposals were approved. The reverse stock split and dilutive issuance approvals are material capital structure events affecting shareholders.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-24T20:46:41.360881+00:00","company_name":"Tenon Medical, Inc.","ticker":"TNONW","filing_date":"2026-07-24"}]}